Mark Gladwell

Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL.

Epocal, Inc. develops and manufactures biochips and micro-fabrication for drug development applications. Its technology includes flex cards, biosensors-on-flex, and fluidics-on-flex. The company was founded by Imants R. Lauks in March 2001 and is headquartered in Ottawa, Canada.

Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD.

Smith & Nephew SRL operates as a medical technology company. Its products include wound care, orthopedic reconstruction, sports medicine, otolaryngology, and traumatology. The company was founded by TJ Smith in 1856 and is headquartered in Agrate Brianza, Italy.

Sapphiros is a privately held consumer diagnostics platform company that invests in growth-stage diagnostic companies. Sapphiros is based in Boston, MA and has subsidiaries in the United Kingdom. The company aims to bridge the gap between present and future by focusing on innovative, patient-centric technologies. Sapphiros' portfolio of capabilities and technologies includes novel sample collection, next generation diagnostics, computational biology, and printed electronics, which help consumers access important diagnostic results quickly. The company empowers exceptional entrepreneurs with the full strength of the platform's resources, capital, and expertise to accelerate and enhance growth and impact. The company was founded by Niall Antony Armes and Namal Nawana. Mark Gladwell has been the CEO of the company since 2021.